-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
ADC Therapeutics SA quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q4 2024.
- ADC Therapeutics SA Costs and Expenses for the quarter ending December 31, 2024 was $49.3M, a 13.1% decline year-over-year.
- ADC Therapeutics SA Costs and Expenses for the twelve months ending December 31, 2024 was $201M, a 14.5% decline year-over-year.
- ADC Therapeutics SA annual Costs and Expenses for 2024 was $201M, a 14.5% decline from 2023.
- ADC Therapeutics SA annual Costs and Expenses for 2023 was $236M, a 29.3% decline from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)